VP22-mediated intercellular transport correlates with enhanced biological activity of MybEngrailed but not (HSV-I) thymidine kinase fusion proteins in primary vascular cells following non-viral transfection

Journal of Gene Medicine

Volumn 7, Issue 3, 2005, Pages 375-385

  Sheridan, Paul J ^a   Lawrie, Allan ^a   Crossman, David C ^a   Holt, Cathy M ^b   Newman, Christopher M ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GANCICLOVIR; PLASMID VECTOR; PROTEIN MYBENGRAILED; PROTEIN VP22; THYMIDINE KINASE; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; APOPTOSIS; ARTICLE; BYSTANDER EFFECT; CARBOXY TERMINAL SEQUENCE; CELL CULTURE; CELL DEATH; CELL GROWTH; CELL TRANSPORT; CONTROLLED STUDY; CORRELATION FUNCTION; DRUG MECHANISM; GAP JUNCTION; GENE EXPRESSION; GENETIC TRANSFECTION; GROWTH INHIBITION; HERPES SIMPLEX VIRUS 1; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; NONVIRAL GENE THERAPY; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER; SWINE; TRANSGENE; VASCULAR SMOOTH MUSCLE;

ANIMALS; APOPTOSIS; BIOLOGICAL TRANSPORT; BYSTANDER EFFECT; CELLS, CULTURED; GENE THERAPY; GENE TRANSFER TECHNIQUES; HERPESVIRUS 1, HUMAN; HOMEODOMAIN PROTEINS; MUSCLE, SMOOTH, VASCULAR; ONCOGENE PROTEINS V-MYB; PLASMIDS; RECOMBINANT FUSION PROTEINS; SWINE; THYMIDINE KINASE; TRANSCRIPTION FACTORS; TRANSFECTION; TRANSGENES; VIRAL STRUCTURAL PROTEINS;

HERPES; SIMPLEXVIRUS; SUIDAE;

EID: 15944420936     PISSN: 1099498X     EISSN: None     Source Type: Journal    
DOI: 10.1002/jgm.679     Document Type: Article

References (37)

1. Newman KD, Dunn PF, Owens JW, et al. Adenovirus-mediated gene transfer into normal rabbit arteries results in prolonged vascular cell activation, inflammation, and neointimal hyperplasia. J Clin Invest 1995; 96: 2955-2965.
2. Isner JM, Vale PR, Symes JF, Losordo DW. Assessment of risks associated with cardiovascular gene therapy in human subjects. Circ Res 2001; 89: 389-400.
3. Elliott G, O'Hare P. Intercellular trafficking and protein delivery by a herpesvirus structural protein. Cell 1997; 88: 223-233.
4. Phelan A, Elliott G, O'Hare P. Intercellular delivery of functional p53 by the herpesvirus protein VP22. Nat Biotechnol 1998; 16: 440-443.
5. Dilber MS, Phelan A, Aints A, et al. Intercellular delivery of thymidine kinase prodrug activating enzyme by the herpes simplex virus protein, VP22. Gene Ther 1999; 6: 12-21.
6. Wills KN, Atencio IA, Avanzini JB, et al. Intratumoral spread and increased efficacy of a p53-VP22 fusion protein expressed by a recombinant adenovirus. J Virol 2001; 75: 8733-8741.
7. Wybranietz WA, Gross CD, Phelan A, et al. Enhanced suicide gene effect by adenoviral transduction of a VP22-cytosine deaminase (CD) fusion gene. Gene Ther 2001; 8: 1654-1664.
8. Zavaglia D, Favrot MC, Eymin B, Tenaud C, Coll JL. Intercellular trafficking and enhanced in vivo antitumour activity of a non-virally delivered P27-VP22 fusion protein. Gene Ther 2003; 10: 314-325.
9. Deter W, Easwaran HP, Knopf CW, Leonhardt H, Cardoso MC. Direct protein transfer to terminally differentiated muscle cells. J Mol Med 1999; 77: 609-613.
10. Liu CS, Kong B, Xia HH, Ellem KA, Wei MQ. VP22 enhanced intercellular trafficking of HSV thymidine kinase reduced the level of ganciclovir needed to cause suicide cell death. J Gene Med 2001; 3: 145-152.
11. Zender L, Kuhnel F, Kock R, Manns M, Kubicka S. VP22-mediated intercellular transport of p53 in hepatoma cells in vitro and in vivo. Cancer Gene Ther 2002; 9: 489-496.
12. Roy I, Holle L, Song W, et al. Efficient translocation and apoptosis induction by adenovirus encoded VP22-p53 fusion protein in human tumor cells in vitro. Anticancer Res 2002; 22: 3185-3189.
13. Zender L, Kock R, Eckhard M, et al. Gene therapy by intrahepatic and intratumoral trafficking of p53-VP22 induces regression of liver tumors. Gastroenterology 2002; 123: 608-618.
14. Lundberg M, Johansson M. Is VP22 nuclear homing an artifact? Nat Biotechnol 2001; 19: 713-714.
15. Falnes PO, Wesche J, Olsnes S. Ability of the Tat basic domain and VP22 to mediate cell binding, but not membrane translocation of the diphtheria toxin A-fragment. Biochemistry 2001; 40: 4349-4358.
16. Qiu Z, Harms JS, Zhu J, Splitter GA. Bovine herpesvirus tegument protein VP22 enhances thymidine kinase/ganciclovir suicide gene therapy for neuroblastomas compared to herpes simplex virus VP22. J Virol 2004; 78: 4224-4233.
17. Badiani P, Corbella P, Kioussis D, Marvel J, Weston K. Dominant interfering alleles define a role for c-Myb in T-cell development. Genes Dev 1994; 8: 770-782.
18. You XM, Mungrue IN, Kalair W, et al. Conditional expression of a dominant-negative c-Myb in vascular smooth muscle cells inhibits arterial remodeling after injury. Circ Res 2003; 92: 314-321.
19. Mesnil M, Yamasaki H. Bystander effect in herpes simplex virus-thymidine kinase/ganciclovir cancer gene therapy: role of gap-junctional intercellular communication. Cancer Res 2000; 60 3989-3999.
20. Nabel EG, Plautz G, Nabel GJ. Site-specific gene expression in vivo by direct gene transfer into the arterial wall. Science 1990; 249: 1285-1288.
21. Guzman RJ, Hirschowitz EA, Brody SL, et al. In vivo suppression of injury-induced vascular smooth muscle cell accumulation using adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene. Proc Natl Acad Sci U S A 1994; 91: 10732-10736.
22. Simari RD, San H, Rekhter M, et al. Regulation of cellular proliferation and intimal formation following balloon injury in atherosclerotic rabbit arteries. J Clin Invest 1996; 98: 225-235.
23. Steg PG, Tahlil O, Aubailly N, et al. Reduction of restenosis after angioplasty in an atheromatous rabbit model by suicide gene therapy. Circulation 1997; 96: 408-411.
24. Geng YJ, Wu Q, Muszynski M, Hansson GK, Libby P. Apoptosis of vascular smooth muscle cells induced by in vitro stimulation with interferon-gamma, tumor necrosis factor-alpha, and interleukin-1 beta. Arterioscler Thromb Vasc Biol 1996; 16: 19-27.
25. Geng YJ, Henderson LE, Levesque EB, Muszynski M, Libby P. Fas is expressed in human atherosclerotic intima and promotes apoptosis of cytokine-primed human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 1997; 17: 2200-2208.
26. Zhang H, Holt CM, Malik N, Shepherd L, Morcos SK. Effects of radiographic contrast media on proliferation and apoptosis of human vascular endothelial cells. Br J Radiol 2000; 73: 1034-1041.
27. Yi HK, Nam SY, Kim JC, et al. Induction of apoptosis in K562 cells by dominant negative c-myb. Exp Hematol 2002; 30: 1139-1146.
28. Chatelin L, Volovitch M, Joliot AH, Perez F, Prochiantz A. Transcription factor hoxa-5 is taken up by cells in culture and conveyed to their nuclei. Mech Dev 1996; 55: 111-117.
29. Ibanez CE, Lipsick JS. Structural and functional domains of the myb oncogene: requirements for nuclear transport, myeloid transformation, and colony formation. J Virol 1988; 62: 1981-1988.
30. Harms JS, Ren X, Oliveira SC, Splitter GA. Distinctions between bovine herpesvirus 1 and herpes simplex virus type 1 VP22 tegument protein subcellular associations. J Virol 2000; 74: 3301-3312.
31. Aints A, Guven H, Gahrton G, Smith CI, Dilber MS. Mapping of herpes simplex virus-1 VP22 functional domains for inter- and subcellular protein targeting. Gene Ther 2001; 8: 1051-1056.
32. Rutjes SA, Bosma PJ, Rohn JL, Noteborn MHM, Wesseling JG. Induction of insolubility by herpes simplex virus VP22 precludes intercellular trafficking of N-terminal Apoptin-VP22 fusion proteins. J Mol Med 2003.81:; 558-565.
33. Touraine RL, Ishii-Morita H, Ramsey WJ, Blaese RM. The bystander effect in the HSVtk/ganciclovir system and its relationship to gap junctional communication. Gene Ther 1998; 5: 1705-1711.
34. Lundberg M, Johansson M. Cell surface adherence and endocytosis of protein transduction domains. Mol Ther 2003; 8 143-150.
35. Cashman SM, Morris DJ, Kumar-Singh R. Evidence of protein transduction but not intercellular transport by proteins fused to HIV tat in retinal cell culture and in vivo. Mol Ther 2003; 8: 130-142.
36. Lai Z, Han I, Zirzow G, Brady RO, Reiser J. Intercellular delivery of a herpes simplex virus VP22 fusion protein from cells infected with lentiviral vectors. Proc Natl Acad Sci U S A 2000; 97: 11 297-11 302-.
37. Kreiss P, Cameron B, Rangara R, et al. Plasmid DNA size does not affect the physicochemical properties of lipoplexes but modulates gene transfer efficiency. Nucleic Acids Res 1999; 27 3792-3798.